Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 2, 2011, Pages 207-215

  Guo, Hai Tao ^a,b   Zhang, Rong Huai ^a   Zhang, Yan ^c   Zhang, Li Jun ^b   Li, Juan ^b   Shi, Quang Xing ^b   Wang, Yue Min ^b   Fan, Rong ^b   Bi, Hui ^b   Yin, Wen ^a   Pei, Jian Ming ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

opioid receptor; apoptosis; dynorphin; heart; postconditioning

Indexed keywords

CASPASE 3; CREATINE KINASE; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; DYNORPHIN; KAPPA OPIATE RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION SIZE; HEART MUSCLE; HEART PROTECTION; HEMODYNAMIC PARAMETERS; IMMUNE RESPONSE; ISCHEMIC POSTCONDITIONING; LACTATE DEHYDROGENASE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NICK END LABELING; NONHUMAN; POSTCONCUSSION SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SPECTROPHOTOMETRY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DYNORPHINS; HEMODYNAMICS; IN SITU NICK-END LABELING; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 80051795848     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318220e37f     Document Type: Article

References (43)

1. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285: H579-H588.
2. Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischaemia in patients: Preconditioning and postconditioning. Cardiovasc Res. 2009;83: 234-246.
3. van Dijk A, Krijnen PA, Vermond RA, et al. Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction. Apoptosis. 2009;14:753-763.
4. Dosenko VE, Nagibin VS, Tumanovska LV, et al. Protective effect of autophagy in anoxia-reoxygenation of isolated cardiomyocyte? Autophagy. 2006;2:305-306.
5. Penna C, Perrelli MG, Raimondo S, et al. Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta. 2009;1787:794-801.
6. Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res. 2006;70:212-221.
7. Jang Y, Xi J, Wang H, et al. Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology. 2008;108:243-250.
8. Okubo S, Tanabe Y, Takeda K, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemiareperfusion in rabbits: Role of delta-opioid receptor. Am J Physiol Heart Circ Physiol. 2004;287:H1786-H1791.
9. Zatta AJ, Kin H, Yoshishige D, et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol. 2008;294:H1444-H1451.
10. Barron BA. Cardiac opioids. Proc Soc Exp Biol Med. 2000;224:1-7.
11. Li R, Wong GT, Wong TM, et al. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesth Analg. 2009;108:23-29.
12. Millington WR, Rosenthal DW, Unal CB, et al. Localization of proopiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res. 1999;43:107-116.
13. Pintus G, Pinna GG, Ventura C. Evaluation of opioid peptide gene expression by solution hybridization RNase protection. Boll Soc Ital Biol Sper. 1994;70:213-219.
14. Spampinato S, Canossa M, Ventura C, et al. Heterogeneity of immunoreactive dynorphin B-like material in human, rat, rabbit and guinea-pig heart. Life Sci. 1991;48:551-559.
15. Canossa M, Ventura C, Vaona I, et al. Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochim Biophys Acta. 1993;1172:247-250.
16. Tai KK, Jin WQ, Chan TK, et al. Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol. 1991; 23:1297-1302.
17. Cheng L, Ma S, Wei LX, et al. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart. Heart Vessels. 2007;22: 335-344.
18. Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/ reperfusion injury in rats by a caspase inhibitor. Circulation. 1998;97: 276-281.
19. You L, Li L, Xu Q, et al. Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway. Mol Biol Rep. 2011;38:437-443.
20. Zhao WS, Xu L, Wang LF, et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis. 2009;14:1204-1211.
21. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: A window of opportunity for cardioprotection. Cardiovasc Res. 2004;61: 365-371.
22. Kin H, Zatta AJ, Lofye MT, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res. 2005;67:124-133.
23. Philipp S, Yang XM, Cui L, et al. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006;70:308-314.
24. Penna C,Mancardi D, Rastaldo R, et al. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res. 2007;75:168-177.
25. Xi L, Das A, Zhao ZQ, et al. Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation. 2008;118(suppl 14):S32-S37.
26. Cohen MV, Yang XM, Liu GS, et al. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res. 2001;89:273-278.
27. Chien GL, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol. 1996;28: 1895-1900.
28. Peart JN, Gross ER, Reichelt ME, et al. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol. 2008;103:454-463.
29. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res. 2008;145:287-294.
30. Rong F, Peng Z, Ye MX, et al. Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist. Arch Med Res. 2009;40:227-234.
31. Tong G, Sun Z,Wei X, et al. U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion. Life Sci. 2011;88:31-38.
32. Wang J, Gao Q, Shen J, et al. Kappa-opioid receptor mediates the cardioprotective effect of ischemic postconditioning. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007;36:41-47.
33. Communal C, Sumandea M, de Tombe P, et al. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A. 2002; 99:6252-6256.
34. Ertracht O, Liani E, Bachner-Hinenzon N, et al. The cardioprotective efficacy of TVP1022 in a rat model of ischemia/reperfusion. Br J Pharmacol. 2011. [Epub ahead of print].
35. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89:123-137.
36. Romano MA, McNish R, Seymour EM, et al. Differential effects of opioid peptides on myocardial ischemic tolerance. J Surg Res. 2004; 119:46-50.
37. Briand LA, Blendy JA. Molecular and genetic substrates linking stress and addiction. Brain Res. 2010;1314:219-234.
38. Romano MA, Seymour EM, Berry JA, et al. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res. 2004; 118:32-37.
39. Sethi R, Saini HK, Guo X, et al. Dependence of changes in betaadrenoceptor signal transduction on type and stage of cardiac hypertrophy. J Appl Physiol. 2007;102:978-984.
40. Pepe S, van den Brink OW, Lakatta EG, et al. Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res. 2004;63:414-422.
41. Bian JS, Zhang WM, Pei JM, et al. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart. J Pharmacol Exp Ther. 2000;292:1065-1070.
42. Shan D, Wang H, Su Y, et al. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat. Eur J Pharmacol. 2007;555:100-105.
43. Zhang SZ, Wang NF, Xu J, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology. 2006;105: 550-556.